- Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments
With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer. - At Work: Immigrant Health and Cancer Disparities Service Chief Francesca M. Gany
Dr. Gany works to identify the causes of health disparities in underserved communities, and to develop ways to more effectively deliver care to ethnically diverse populations. - Alexander Rudensky Appointed Immunology Program Chair
Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan-Kettering Institute in 2009. - Two Memorial Sloan-Kettering Studies Focus on Role of Antibiotics in Stem Cell Transplantation
Researchers examined how changes in the microbiota may make patients more susceptible to severe infections and other complications. - Pediatric Oncologist Scott Armstrong Joins Memorial Sloan-Kettering
Dr. Armstrong has made significant contributions to the understanding of the origins of leukemia. He has joined Memorial Sloan-Kettering as a Member in the Department of Pediatrics and the Human Oncology and Pathogenesis Program. - Experimental Therapeutics Center Marks Ten-Year Anniversary
Scientific presentations and discussions took place at the May 23rd retreat of this institution-wide center aimed at facilitating the translation of basic science discoveries into new therapeutic strategies.
Inside MSKCC
|
©2013 Memorial Sloan-Kettering Cancer Center